Apollomics Class A Stock Analysis

APLM Stock   18.81  0.21  1.13%   
Below is the normalized historical share price chart for Apollomics Class A extending back to November 26, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Apollomics stands at 18.81, as last reported on the 6th of February, with the highest price reaching 18.81 and the lowest price hitting 18.60 during the day.
IPO Date
26th of November 2021
200 Day MA
9.1432
50 Day MA
17.0897
Beta
1.811
 
Covid
 
Interest Hikes
At this time, Apollomics' Net Debt To EBITDA is very stable compared to the past year. As of the 6th of February 2026, Debt To Equity is likely to grow to 0.19, though Net Debt is likely to grow to (7.5 M). Apollomics' financial risk is the risk to Apollomics stockholders that is caused by an increase in debt.
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.0848
Current Value
0.0806
Quarterly Volatility
0.84079681
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At this time, Apollomics' Total Stockholder Equity is very stable compared to the past year. As of the 6th of February 2026, Other Stockholder Equity is likely to grow to about 848 M, while Common Stock Shares Outstanding is likely to drop about 685.6 K. . At this time, Apollomics' Price Book Value Ratio is very stable compared to the past year. As of the 6th of February 2026, Price Earnings To Growth Ratio is likely to grow to 0, while Price Earnings Ratio is likely to drop (0.16).
Apollomics Class A is overvalued with Real Value of 10.34 and Target Price of 2.0. The main objective of Apollomics stock analysis is to determine its intrinsic value, which is an estimate of what Apollomics Class A is worth, separate from its market price. There are two main types of Apollomics' stock analysis: fundamental analysis and technical analysis.
The Apollomics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Apollomics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Apollomics Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Apollomics Stock Analysis Notes

The company recorded a loss per share of 52.8. Apollomics Class A had not issued any dividends in recent years. The entity had 1:100 split on the 25th of November 2024. For more info on Apollomics Class A please contact HungWen Chen at 650 209 4055 or go to https://www.apollomicsinc.com.

Apollomics Class A Investment Alerts

Apollomics Class A is way too risky over 90 days horizon
Apollomics Class A appears to be risky and price may revert if volatility continues
Apollomics Class A has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 198 K. Net Loss for the year was (53.86 M) with profit before overhead, payroll, taxes, and interest of 198 K.
Apollomics generates negative cash flow from operations
Apollomics Class A has a poor financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Apollomics Upgraded at Wall Street Zen

Apollomics Largest EPS Surprises

Earnings surprises can significantly impact Apollomics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-04-03
2025-03-31-0.15-16.92-16.7711180 
View All Earnings Estimates

Apollomics Environmental, Social, and Governance (ESG) Scores

Apollomics' ESG score is a quantitative measure that evaluates Apollomics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Apollomics' operations that may have significant financial implications and affect Apollomics' stock price as well as guide investors towards more socially responsible investments.

Apollomics Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 44.92 M.

Apollomics Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(5.45)(5.18)
Return On Capital Employed(8.50)(8.08)
Return On Assets(4.73)(4.49)
Return On Equity(12.73)(12.10)

Management Efficiency

Apollomics Class A has return on total asset (ROA) of (0.7507) % which means that it has lost $0.7507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.3367) %, meaning that it created substantial loss on money invested by shareholders. Apollomics' management efficiency ratios could be used to measure how well Apollomics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 6th of February 2026, Return On Tangible Assets is likely to grow to -5.18. In addition to that, Return On Capital Employed is likely to grow to -8.08. As of the 6th of February 2026, Total Assets is likely to drop to about 11.2 M. In addition to that, Non Current Assets Total is likely to drop to about 2.4 M
Last ReportedProjected for Next Year
Book Value Per Share 4.73  4.96 
Tangible Book Value Per Share 3.04  3.19 
Enterprise Value Over EBITDA(0.01)(0.01)
Price Book Value Ratio 1.67  1.75 
Enterprise Value Multiple(0.01)(0.01)
Price Fair Value 1.67  1.75 
Enterprise Value209.8 K186.5 K
The decision-making processes within Apollomics are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin
10.0739
Beta
1.811
Return On Assets
(0.75)
Return On Equity
(2.34)

Technical Drivers

As of the 6th of February, Apollomics shows the Mean Deviation of 6.17, downside deviation of 7.07, and Risk Adjusted Performance of 0.0786. Apollomics Class A technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apollomics Class A coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Apollomics Class A is priced correctly, providing market reflects its regular price of 18.81 per share. Given that Apollomics has jensen alpha of 0.7134, we suggest you to validate Apollomics Class A's prevailing market performance to make sure the company can sustain itself at a future point.

Apollomics Class A Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Apollomics Class A price data points by creating a series of averages of different subsets of Apollomics entire price series.

Apollomics Class A Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apollomics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apollomics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apollomics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Apollomics Outstanding Bonds

Apollomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apollomics Class A uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apollomics bonds can be classified according to their maturity, which is the date when Apollomics Class A has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Apollomics Predictive Daily Indicators

Apollomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apollomics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Apollomics Corporate Filings

2nd of February 2026
Other Reports
ViewVerify
6K
22nd of December 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
12th of December 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
19th of November 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
18th of November 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
21st of October 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
16th of October 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
14th of October 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify

Apollomics Forecast Models

Apollomics' time-series forecasting models are one of many Apollomics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apollomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Apollomics Bond Ratings

Apollomics Class A financial ratings play a critical role in determining how much Apollomics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Apollomics' borrowing costs.
Piotroski F Score
4
PoorView
Beneish M Score
(10.94)
Unlikely ManipulatorView

Apollomics Total Assets Over Time

Apollomics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Apollomics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Apollomics Debt Ratio

    
  8.06   
It appears that most of the Apollomics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Apollomics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Apollomics, which in turn will lower the firm's financial flexibility.

Apollomics Corporate Bonds Issued

Apollomics Short Long Term Debt Total

Short Long Term Debt Total

825,930

At this time, Apollomics' Short and Long Term Debt Total is very stable compared to the past year.

About Apollomics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Apollomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Apollomics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Apollomics. By using and applying Apollomics Stock analysis, traders can create a robust methodology for identifying Apollomics entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(311.31)(326.87)
Operating Profit Margin(191.53)(201.10)
Net Loss(244.81)(257.05)

Current Apollomics Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Apollomics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Apollomics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceConsensus# of Analysts
2.0Buy1Odds
Apollomics Class A current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Apollomics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Apollomics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Apollomics Class A, talking to its executives and customers, or listening to Apollomics conference calls.
Apollomics Analyst Advice Details

Apollomics Stock Analysis Indicators

Apollomics Class A stock analysis indicators help investors evaluate how Apollomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Apollomics shares will generate the highest return on investment. By understating and applying Apollomics stock analysis, traders can identify Apollomics position entry and exit signals to maximize returns.
Begin Period Cash Flow32.1 M
Common Stock Shares Outstanding926.5 K
Total Stockholder Equity4.9 M
Total Cashflows From Investing ActivitiesM
Tax Provision259 K
Property Plant And Equipment NetM
Cash And Short Term Investments9.8 M
Cash9.8 M
Net Debt-8.8 M
50 Day M A17.0897
Total Current Liabilities7.4 M
Other Operating Expenses42.3 M
Non Current Assets Total2.8 M
Non Currrent Assets Other75 K
Stock Based Compensation10.9 M
When determining whether Apollomics Class A is a strong investment it is important to analyze Apollomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apollomics' future performance. For an informed investment choice regarding Apollomics Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Biotechnology sector continue expanding? Could Apollomics diversify its offerings? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apollomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(52.80)
Revenue Per Share
0.194
Quarterly Revenue Growth
2.623
Return On Assets
(0.75)
Return On Equity
(2.34)
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apollomics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apollomics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apollomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.